Omnicell

SEPTEMBER 5, 2022

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. million preventable adverse drug events a year , resulting in $5.1 An ISMP Pulse Check of Sterile Compounding Practices” as part of Omnicell Illuminate 2020.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Documentation 52

Omnicell

SEPTEMBER 5, 2022

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Labelling 52

Omnicell

JANUARY 10, 2023

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

MARCH 27, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52